July 26, 2021 -- Collaborative Drug Discovery has launched a new database called BioHarmony that offers continually updated drug data from a variety of sources.
BioHarmony consists of a centralized and standardized data format for preclinical, clinical, and postapproval sources, the company said. Users can export the data at any time in both computer- and human-readable formats. The database updates regularly and new feeds are available on demand, according to the firm.
Information regarding top revenue-generating drugs and potential repurposed COVID-19 drugs is available via online subscription in the BioHarmony content store. Each report contains drug, target, clinical trial, variant, safety, financial, and commercial information as well as drug indications and trends.
Copyright © 2021 scienceboard.net